Determining Personal and Professional Work/Life Balance in GU Oncology

Commentary
Video

Two women in genitourinary oncology discuss their experiences with figuring out when to begin a family and how to prioritize both work and children.

Work-life balance can be especially difficult for female physicians in genitourinary (GU) oncology, given the demanding nature of the field.

In a recent conversation with CancerNetwork® in Breaking Barriers: Women in Oncology, Maha H. Hussain, MD, and Sarah E. Fenton, MD, PhD, focused on how they decided to start families and if it impacted their work.

Hussain, a Genevieve E. Teuton Professor of Medicine at Northwestern Medicine, recalled working through residency while she was pregnant and determined that having a family was important to her, but so was her job.

Fenton, an assistant professor of Medicine at Northwestern Medicine, said she struggled with finding the perfect timing to start a family but eventually learned how to balance her professional and personal life.

Transcript:

Fenton: I don’t know that this is GU-specific, but one thing as a woman entering the field of medicine or entering any profession where you have to put a lot of work into it is that I remember struggling with the family part of it. I wanted children; I knew that was important to me. When would that figure in? How am I going to do that? I remember talking to one of my residency mentors, who [said] there are seasons to your career. If you end up having kids, and that becomes a period where you’re not putting hours, weekends, and all this time into work because you have a newborn, that’s okay. You have to think a little bit broader and recognize that even if at this moment, you feel like you’re not 1000% at work, it’s going to be that way in the future. [Work is like] seasons that shift from day to day and week to week, and you just need to think about what’s important to you and try to attain all those things. That shifted my way of thinking about starting a family, which was an important thing to me. I have 2 little kids, and they’re the best.

Hussain: Family is very important. As women, it’s very critical to balance the personal life and the professional life. Being a mother doesn’t give you credit in your career, technically; that’s a reality. I would say sleep is overrated, work hard, and figure out how to balance things. As a person who came from Iraq—I’m from Baghdad, was born and raised there, and did my medical school there—[my family] came in as immigrants. As interns, when we started our careers, we made 5 bucks; well, maybe not exactly 5 bucks. My salary in my first year was $17,000. I was pregnant the whole year, we were on call every third night, and I could do it. The point here is this: you have to be setting yourself up and deciding your priorities. You can parallel-track your career and your personal life. I would say motherhood is wonderful. It’s a wonderful opportunity to be a mother. At the same time, it was a wonderful opportunity to be a physician and move the field there and work hard. Don’t forget that your personal life is very important because a happy personal life also reflects on your work life.

Recent Videos
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Establishment of an AYA Lymphoma Consortium has facilitated a process to better understand and address gaps in knowledge for this patient group.
Adult and pediatric oncology collaboration in assessing nivolumab in advanced Hodgkin lymphoma facilitated the phase 3 SWOG S1826 findings.
Treatment paradigms differ between adult and pediatric oncologists when treating young adults with lymphoma.
Differences in pancreatic cancer responses to treatment elicits a need to better educate patients on expectations in treatment, particularly chemotherapy.
Increasing patient awareness of modifiable risk factors for pancreatic cancer may help mitigate incidence of pancreatic cancers.
It may be crucial to test every patient for markers such as BRAF V600E mutations, NRG1 fusions, and KRAS G12C mutations to help manage pancreatic cancers.
Tanios S. Bekaii-Saab, MD, emphasizes the idea of moving targeted therapies to earlier lines of treatment to further improve outcomes in pancreatic cancer.
The Together for Supportive Cancer Care coalition may advance the national conversation in ensuring comprehensive care for all patients with cancer.
Related Content